Martingale Asset Management’s Guardian Pharmacy Services GRDN Stock Holding History

Martingale Asset Management’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$226K	Buy	+6,004	New	+$196K	0.01%	764

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Martingale Asset Management's GRDN Position: Q1 2026 in Review

Martingale Asset Management opened a new position in Guardian Pharmacy Services (GRDN) in Q1 2026: 6,004 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #764 among its holdings.

171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

Martingale Asset Management held 6,004 shares of Guardian Pharmacy Services worth $226K as of Q1 2026.
Guardian Pharmacy Services was a new Martingale Asset Management position in Q1 2026.
Guardian Pharmacy Services made up 0.01% of Martingale Asset Management's portfolio in Q1 2026, its #764 holding.
171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.